We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Artificial Human Skin Created Using Tissue Engineering

By LabMedica International staff writers
Posted on 03 May 2010
A new study describes the development of artificial human skin with biomechanical properties, based on an agarose-fibrin biomaterial.

Researchers at the University of Granada (UGR; Spain) first obtained human skin samples from biopsies of patients who underwent plastic surgery at the University Hospital Virgen de las Nieves (Granada, Spain). More...
To create the artificial human skin, tranexamic acid (to prevent fibrinolysis), calcium chloride (to precipitate fibrin coagulation), and 0.1% agarose was added to human fibrin from plasma of healthy donors. The artificial-skin substitutes were then grafted on the back of the nude mice, with the purpose of observing its optimal development, maturation, and functionality in vivo. To do so, the researchers analyzed the samples by transmission and scanning light, electron microscopy, and inmunofluorescence to evaluate factors such as cell proliferation, the presence of differentiating morphological markers, the expression of cytokeratin, involucrine, filaggrin, and angiogenesis of the artificial skin into the recipient organism.

The researchers found that the artificial human skin created in the laboratory showed adequate biocompatibility rates with the recipient, and no rejection, dehiscence, or infection was registered. Additionally, the skin of all animals used in the study started to show granulation after six days from implantation. Within the following twenty days, cicatrization was complete. Details on the research were released by the department of histology at UGR on April 20, 2010.

"These biomaterials added resistance, firmness, and elasticity to the skin. Definitively, we have created a more stable skin with similar functionality to normal human skin,” said lead author José María Jiménez Rodríguez, of the tissular engineering research group at UGR. ”This pioneering finding will allow the clinical use of human skin and its use in many laboratory tests on biological tissues. Further, this finding could be useful in developing new treatment approaches for dermatological pathologies.”

Related Links:
University of Granada
University Hospital Virgen de las Nieves


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.